Glycan Shielding Enables TCR-Sufficient Allogeneic CAR-T Therapy
🔬 SPPL3 deletion enhances T cell glycosylation patterns

#CAR-T #B-NHL #CancerTherapy #Pub2Post
https://tnyp.me/FbhvQ66a/m